rs28751578

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001277115.2(DNAH11):​c.9098T>C​(p.Ile3033Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00311 in 1,576,640 control chromosomes in the GnomAD database, including 151 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I3033V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.016 ( 71 hom., cov: 31)
Exomes 𝑓: 0.0017 ( 80 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.84

Publications

4 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003173232).
BP6
Variant 7-21765585-T-C is Benign according to our data. Variant chr7-21765585-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 238940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0549 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.9098T>C p.Ile3033Thr missense_variant Exon 55 of 82 ENST00000409508.8 NP_001264044.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.9098T>C p.Ile3033Thr missense_variant Exon 55 of 82 5 NM_001277115.2 ENSP00000475939.1

Frequencies

GnomAD3 genomes
AF:
0.0162
AC:
2389
AN:
147518
Hom.:
71
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0567
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00461
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000659
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00325
Gnomad NFE
AF:
0.000149
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00388
AC:
928
AN:
239040
AF XY:
0.00318
show subpopulations
Gnomad AFR exome
AF:
0.0551
Gnomad AMR exome
AF:
0.00219
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000574
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000837
Gnomad OTH exome
AF:
0.00170
GnomAD4 exome
AF:
0.00175
AC:
2500
AN:
1428996
Hom.:
80
Cov.:
31
AF XY:
0.00149
AC XY:
1059
AN XY:
710008
show subpopulations
African (AFR)
AF:
0.0643
AC:
2114
AN:
32898
American (AMR)
AF:
0.00238
AC:
103
AN:
43356
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24756
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39014
South Asian (SAS)
AF:
0.000176
AC:
15
AN:
85254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50054
Middle Eastern (MID)
AF:
0.00257
AC:
14
AN:
5456
European-Non Finnish (NFE)
AF:
0.0000202
AC:
22
AN:
1089846
Other (OTH)
AF:
0.00398
AC:
232
AN:
58362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
98
196
293
391
489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0163
AC:
2400
AN:
147644
Hom.:
71
Cov.:
31
AF XY:
0.0161
AC XY:
1154
AN XY:
71676
show subpopulations
African (AFR)
AF:
0.0568
AC:
2292
AN:
40352
American (AMR)
AF:
0.00461
AC:
67
AN:
14546
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3422
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5080
South Asian (SAS)
AF:
0.000659
AC:
3
AN:
4554
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9454
Middle Eastern (MID)
AF:
0.00350
AC:
1
AN:
286
European-Non Finnish (NFE)
AF:
0.000149
AC:
10
AN:
67016
Other (OTH)
AF:
0.0132
AC:
27
AN:
2044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
102
203
305
406
508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00798
Hom.:
17
Bravo
AF:
0.0182
ESP6500AA
AF:
0.0521
AC:
217
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.00512
AC:
619
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Benign:3
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 17, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.29
.;.;T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.026
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.69
T;T;T
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
4.8
PrimateAI
Benign
0.38
T
PROVEAN
Uncertain
-3.8
.;D;.
REVEL
Benign
0.087
Sift
Uncertain
0.021
.;D;.
Vest4
0.34
MVP
0.42
ClinPred
0.027
T
GERP RS
4.5
Varity_R
0.17
gMVP
0.21
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28751578; hg19: chr7-21805203; API